Recombinant viruses of poultry as vector vaccines against fowl plague;Rekombinante geflügelviren als vektorimpfstoffe gegen geflügelpest

Berliner und Munchener Tierarztliche Wochenschrift

Volumn 119, Issue 3-4, 2006, Pages 160-166

  Fuchs, Walter ^a   Veits, Jutta ^a   Mettenleiter, Thomas C ^a  

^a FEDERAL RESEARCH INSTITUTE FOR ANIMAL HEALTH   (Germany)

Author keywords

Avian influenza virus (AIV); Fowlpox virus (FPV); Infectious laryngotracheitis virus (ILTV); Marker vaccines; Newcastle disease virus (NDV); Viral vectors

Indexed keywords

INFLUENZA VACCINE; LIVE VACCINE; MARKER VACCINE; RECOMBINANT VACCINE;

ANIMAL; ANIMAL DISEASE; AVIAN INFLUENZA; BIRD; CLASSIFICATION; FOWLPOX VIRUS; GENE VECTOR; ILTOVIRUS; IMMUNOLOGY; INFLUENZA VIRUS A; POULTRY; REVIEW; VACCINATION; VARICELLA ZOSTER VIRUS; VIROLOGY; VIRUS INFECTION;

ANIMALS; BIRDS; FOWLPOX VIRUS; GENETIC VECTORS; HERPESVIRUS 1, GALLID; INFLUENZA A VIRUS; INFLUENZA IN BIRDS; INFLUENZA VACCINES; POULTRY; VACCINATION; VACCINES, ATTENUATED; VACCINES, MARKER; VACCINES, SYNTHETIC; VIRUS DISEASES;

ANIMALIA; AVES; AVIAN INFLUENZA VIRUS; FOWLPOX VIRUS; GALLID HERPESVIRUS 1; INFLUENZA A VIRUS; INFLUENZAVIRUS A; NEWCASTLE DISEASE VIRUS; ORTHOMYXOVIRIDAE;

EID: 33645033063     PISSN: 00059366     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Alexander, D. J. (2000): A review of avian influenza in different bird species. Vet Microbiol. 74, 3-13.
2. Alexander, D. J. (2003): Newcastle Disease. In: Saif Y. M., Barnes, H. J., Glisson, J. R., Fadly, A. M., McDougald, L. R., Swayne D. E., eds. Diseases of Poultry. Ames: Iowa State Press, 64-87.
3. Capua, I., C. Terregino, G. Cattoli, F. Mutinelli, J. F. Rodriguez (2003): Development of a DIVA (Differentiating Infected from Vaccinated Animals) strategy using a vaccine containing a heterologous neuraminidase for the control of avian influenza. Avian Pathol. 32, 47-55.
4. Capua, I., G. Cattoli, S. Marangon (2004): DIVA - A vaccination strategy enabling the detection of field exposure to avian influenza. Dev. Biol. 119, 229-333.
5. Crawford, J., B. Wilkinson, A. Vosnesensky, G. Smith, M. Garcia, H. Stone, M. L. Perdue (1999): Baculovirus-derived hemagglutinin vaccines protect against lethal influenza infections by avian H5 and H7 subtypes. Vaccine 17, 2265-2274.
6. de Boer, G .F., W. Back, A. D. Osterhaus (1990): An ELISA for detection of antibodies against influenza A nucleoprotein in humans and various animal species. Arch. Virol. 115, 47-61.
7. Domi, A., B. Moss (2002): Cloning the vaccinia virus genome as a bacterial artificial chromosome in Escherichia coli and recovery of infectious virus in mammalian cells. Proc. Natl. Acad. Sci. U.S.A. 99, 12415-12420.
8. Huang, Z., S. Elankumaran, A. S. Yunus, S. K. Samal (2004): A recombinant Newcastle disease virus (NDV) expressing VP2 protein of infectious bursal disease virus (IBDV) protects against NDV and IBDV. J. Virol. 78, 10054-10063.
9. Francois, A., N. Eterradossi, B. Delmas, V. Payet, P. Langlois (2001): Construction of avian adenovirus CELO recombinants in cosmids. J. Virol. 75, 5288-5301.
10. Francois, A., C. Chevalier, B. Delmas, N. Eterradossi, D. Toquin, G. Rivallan, P. Langlois (2004): Avian adenovirus CELO recombinants expressing VP2 of infectious bursal disease virus induce protection against bursal disease in chickens. Vaccine 22, 2351-2360.
11. Fuchs, W., D. Wiesner, J.Veits, J. P. Teifke, T. C. Mettenleiter (2005): In vitro and in vivo relevance of infectious laryngotracheitis virus gJ proteins that are expressed from spliced and nonspliced mRNAs. J. Virol. 79, 705-716.
12. Guy, J. S., T. J.Bagust (2003): Laryngotracheitis. In: SaifY. M., Barnes, H. J., Glisson, J. R., Fadly, A. M., McDougald, L. R., Swayne D. E., eds. Diseases of Poultry. Ames: Iowa State Press, 121-134.
13. Hoffmann, E., S. Krauss, D. Perez, R. Webby, R. G. Webster (2002): Eight-plasmid system for rapid generation of influenza virus vaccines. Vaccine 20, 3165-3170.
14. Kodihalli, S., D. L. Kobasa, R. G. Webster (2000): Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines. Vaccine 18, 2592-2599.
15. Lee, W. C., D. A. Senne, D. L. Suarez (2004): Generation of reassortant influenza vaccines by reverse genetics that allows utilization of a DIVA (Differentiating Infected from Vaccinated Animals) strategy for the control of avian influenza. Vaccine 22, 3175-3181.
16. Lüschow, D., O. Werner, T. C. Mettenleiter, W. Fuchs (2001): Protection of chickens from lethal avian influenza A virus infection by live-virus vaccination with infectious laryngotracheitis virus recombinants expressing the hemagglutinin (H5) gene. Vaccine 19, 4249-4259.
17. Messerle, M., I. Crnkovic, W. Hammerschmidt, H. Ziegler, U. H. Koszinowski (1997): Cloning and mutagenesis of a herpesvirus genome as an infectious bacterial artificial chromosome. Proc. Natl. Acad. Sci. U.S.A. 94, 14759-14763.
18. Morgan, R. W., J. Gelb Jr., C. S. Schreurs, D. Lütticken, J. K. Rosenberger, P. J. Sondermeijer (1992): Protection of chickens from Newcastle and Marek's diseases with a recombinant herpesvirus of turkeys vaccine expressing the Newcastle disease virus fusion protein. Avian Dis. 36, 858-870.
19. Nakaya, T., J. Cros, M. S. Park, Y. Nakaya, H. Zheng, A. Sagrera, E. Villar, A. Garcia-Sastre, P. Palese (2001): Recombinant Newcastle disease virus as a vaccine vector. J. Virol. 75, 11868-11873.
20. Neumann, G., T. Watanabe, H. Ito, S. Watanabe, H. Goto, P. Gao, M. Hughes, D. R. Perez, R. Donis, E. Hoffmann, G. Hobom, Y. Kawaoka (1999): Generation of influenza A viruses entirely from cloned cDNAs. Proc. Natl. Acad. Sci. U.S.A. 96, 9345-9350.
21. Peeters, B .P., O. S. de Leeuw, G. Koch, A. L. Gielkens (1999): Rescue of Newcastle disease virus from cloned cDNA: evidence that cleavability of the fusion protein is a major determinant for virulence. J. Virol. 73, 5001-5009.
22. Qiao, C. L., K. Z. Yu, Y. P. Jiang, Y. Q. Jia, G. B. Tian, M. Liu, D. H. Deng, X. R. Wang, Q. W. Meng, X. Y. Tang (2003): Protection of chickens against highly lethal H5N1 and H7N1 avian influenza viruses with a recombinant fowlpox virus co-expressing H5 haemagglutinin and N1 neuraminidase genes. Avian Pathol. 32, 25-32.
23. Römer-Oberdörfer, A., E. Mundt, T. Mebatsion, U. J. Buchholz, T. C. Mettenleiter (1999): Generation of recombinant lentogenic Newcastle disease virus from cDNA. J. Gen. Virol. 80, 2987-2995.
24. Schnitzlein, W. M., R. Winans, S. Ellsworth, D. N. Tripathy (1995): Generation of thymidine kinase-deficient mutants of infectious laryngotracheitis virus. Virology 209, 304-314.
25. Shafer, A. L., J. B. Katz, K. A. Eernisse (1998): Development and validation of a competitive enzyme-linked immunosorbent assay for detection of type A influenza antibodies in avian sera. Avian Dis. 42, 28-34.
26. Suarez, D. L. (2005): Overview of avian influenza DIVA test strategies. Biologicals 33, 221-226.
27. Swayne, D. E., J. R. Beck, M. Carcia, H. D. Stone (1999): Influence of virus strain and antigen mass on efficacy of H5 avian influenza inactivated vaccines. Avian Pathol. 28, 245-255.
28. Swayne, D. E., M. Garcia, J. R. Beck, N. Kinney, D. L. Suarez (2000a): Protection against diverse highly pathogenic H5 avian influenza viruses in chickens immunized with a recombinant fowlpox vaccine containing an H5 avian influenza hemagglutinin gene insert. Vaccine 18, 1088-1095.
29. Swayne, D. E., J. R. Beck, N. Kinney (2000b): Failure of a recombinant fowl poxvirus vaccine containing an avian influenza hemagglutinin gene to provide consistent protection against influenza in chickens preimmunized with a fowl pox vaccine. Avian Dis. 44, 132-137.
30. Swayne, D. E. (2003): Vaccines for List A poultry diseases: emphasis on avian influenza. Dev. Biol. 114, 201-212.
31. Swayne, D. E., D. A. Halvorson (2003): Influenza. In: SaifY. M., Barnes, H. J., Glisson, J. R., Fadly, A. M., McDougald, L. R., Swayne D. E., eds. Diseases of Poultry. Ames: Iowa State Press, 135-160.
32. Swayne, D. E., D. L. Suarez, S. Schultz-Cherry, T. M. Tumpey, D. J. King, T. Nakaya, P. Palese, A. Garcia-Sastre (2003): Recombinant paramyxovirus type 1-avian influenza-H7 virus as a vaccine for protection of chickens against influenza and Newcastle disease. Avian Dis. 47, 1047-1050.
33. Swayne, D. E. (2004): Application of new vaccine technologies for the control of transboundary diseases. Dev. Biol. 119, 219-228.
34. Tang, M., J. A. Harp, R. D. Wesley (2002): Recombinant adenovirus encoding the HA gene from swine H3N2 influenza virus partially protects mice from challenge with heterologous virus: A/HK/1/68 (H3N2). Arch.Virol. 147, 2125-2141.
35. Taylor, J., R. Weinberg, Y. Kawaoka, R. G. Webster, E. Paoletti (1988): Protective immunity against avian influenza induced by a fowlpox virus recombinant. Vaccine 6, 504-508.
36. Tripathy, D. N., W. M. Schnitzlein (1991): Expression of avian influenza virus hemagglutinin by recombinant fowlpox virus. Avian Dis. 35, 186-191.
37. Tripathy, D. N., W.M. Reed (2003): Pox. In: Saif Y. M., Barnes, H. J., Glisson, J. R., Fadly, A. M., McDougald, L. R., Swayne D. E., eds. Diseases of Poultry. Ames: Iowa State Press, 253-270.
38. Tumpey, T. M., R. Alvarez, D. E. Swayne, D. L. Suarez (2005): Diagnostic approach for differentiating infected from vaccinated poultry on the basis of antibodies to NS1, the nonstructural protein of influenza A virus. J. Clin. Microbiol. 43, 676-683.
39. van Oirschot, J. T. (1999): Diva vaccines that reduce virus transmission. J. Biotechnol. 73, 195-205.
40. Veits, J., D. Lüschow, K. Kindermann, O. Werner, J. P. Teifke, T. C. Mettenleiter, W. Fuchs (2003): Deletion of the non-essential UL0 gene of infectious laryngotracheitis (ILT) virus leads to attenuation in chickens, and UL0 mutants expressing influenza virus haemagglutinin (H7) protect against ILT and fowl plague. J. Gen.Virol. 84, 3343-3352.
41. Webster, R. G., Y. Kawaoka, J. Taylor, R. Weinberg, E. Paoletti (1991): Efficacy of nucleoprotein and haemagglutinin antigens expressed in fowlpox virus as vaccine for influenza in chickens. Vaccine 9, 303-308.